Med BioGene Provides GeneFx(R) Lung Regulatory and Commercialization Update
November 05, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 5, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update on the regulatory and commercialization plans for GeneFx®...
Med BioGene Announces Grant of Stock Options
September 20, 2013 14:13 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 20, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that, effective September 19, 2013, MBI granted to certain directors and...
Med Biogene Announces Discontinuance of Petition by Dissident Shareholders
August 30, 2013 13:37 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 30, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that the petition (the "Petition") filed by certain shareholders of MBI...
Med BioGene Reports Financial Results for Q2 2013
August 29, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 29, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the six months ended June 30, 2013 (all amounts...
Med BioGene Announces Settlement Agreement for the Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC
August 22, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 22, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that MBI and its commercial partner, Precision Therapeutics, Inc., have...
Med BioGene Announces Hearing Date for Petition by Dissident Shareholders
August 21, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 21, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that the petition (the "Petition") filed by certain shareholders of MBI...
Med BioGene Announces Petition by Dissident Shareholders
June 05, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 5, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that on June 4, 2013 certain shareholders of MBI served the company with a...
Med BioGene Announces GeneFx(R) Lung ASCO Presentation and Provides Commercialization Update
June 03, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 3, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that its commercial partner, Precision Therapeutics, Inc., presented data...
Med BioGene Reports Financial Results for Q1 2013
May 30, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the three months ended March 31, 2013 (all amounts...
Med BioGene Announces Warrant Exercises
May 24, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 24, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that 2,318,000 warrants and agents' warrants to purchase an equal number of...